Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/02/21
End: 11/13/23
Due: 11/13/24
Phase: N/A
Priority: Normal
Start: 09/21/23
End: 10/31/25
Due: 10/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC) | NCT04926376 | ABK Biomedical | user2@example.com | None | 2021-11-02 | 2023-11-13 | 2024-11-13 | - | - | 2025-07-14 |
| Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) | NCT05953337 | ABK Biomedical | user2@example.com | None | 2023-09-21 | 2025-10-31 | 2026-10-31 | - | - | 2025-07-14 |